Literature DB >> 2897724

Qualitative analysis of chromosomal evolution in a colcemid-treated Chinese hamster population.

S Simi1, C M Colella, T Mariani, A Piras, G Rainaldi.   

Abstract

Colcemid is known to inhibit the spindle formation and to induce polyploidy and chromosomal nondisjunction. Using a V79 Chinese hamster cell line, we have shown that colcemid is able to induce the formation of cells that are numerically diploid but whose karyotype, when analyzed with the G-banding technique, differs from that of the untreated ones. Even though these cells have a normal chromosomal constitution, they carry alterations in the chromosomal balance and, consequently, in gene dosage. This could result in an abnormal expression of cellular genes or in the expression of new or preexisting recessive mutations, even in a diploid chromosomal constitution.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897724     DOI: 10.1002/tcm.1770080106

Source DB:  PubMed          Journal:  Teratog Carcinog Mutagen        ISSN: 0270-3211


  4 in total

1.  Intrachromosomal telomere-like DNA sequences in Chinese hamster.

Authors:  L Bertoni; C Attolini; M Faravelli; S Simi; E Giulotto
Journal:  Mamm Genome       Date:  1996-11       Impact factor: 2.957

2.  Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy.

Authors:  P Duesberg; R Stindl; R Hehlmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

3.  Reduced cardiotoxicity and increased cytotoxicity in a novel anthracycline analogue, 4'-amino-3'-hydroxy-doxorubicin.

Authors:  R Danesi; N Bernardini; C Agen; M Costa; L Zaccaro; D Pieracci; G Malvaldi; M Del Tacca
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Involvement of basic fibroblast growth factor in suramin-induced inhibition of V79/AP4 fibroblast cell proliferation.

Authors:  N Bernardini; F Giannessi; F Bianchi; A Dolfi; M Lupetti; L Citti; R Danesi; M Del Tacca
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.